In situ hybridization at 7 days for the activated mouse (m)-pericyte marker Rgs5, a gene controlling tumor vasculature remodeling [27], [28], showed the presence of m-Rgs5+-cells surrounding abnormally dilated vessels throughout the graft (Figure 1I–K). Here, RGS5 is linked to neoplasm.